+150.5%
SPMO vs VRSK
-11.8%
+162.3%
-22.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VRSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.2% | +0.3% | +0.5% |
| 7D | -0.9% | -5.2% | +4.2% | -0.4% |
| 30D | -1.9% | -2.3% | +0.4% | -1.8% |
| 3M | -1.4% | -2.9% | +1.6% | -1.9% |
| 6M | +25.5% | -12.8% | +38.3% | +27.5% |
| YTD | +24.8% | -20.8% | +45.7% | +29.7% |
| 1Y | +24.5% | -33.2% | +57.7% | +35.8% |
| 3Y | +157.1% | -26.6% | +183.7% | +166.6% |
| All | +150.5% | -11.8% | +162.3% | +136.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSK.
Daily Out/Under-Performance
Portfolio return minus VRSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VRSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling